Public company info - Innovent Biologics Inc. , 01801.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Innovent Biologics Inc., 01801.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -1,852,705 -1,998,399 -167,980 -1,678,199 -1,016,019 -492,270 -362,993
Net Cash Flow from Return on Investments & Servicing of Finance 2,375 72,814 75,470 29,216 -8,063 -20,086 -22,382
　Interest Received 107,259 151,640 121,299 70,532 24,784 4,755 4,217
　Interest Paid -104,884 -78,826 -45,829 -41,316 -32,847 -24,841 -26,599
　Dividend Received 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -66,099 -26,444 -139,708 13,726 0 0 0
Net Cash Flow from Investing Activities -1,542,444 -2,849,788 -5,305,887 -2,639,689 834,633 -354,211 -576,296
　Additions to Fixed Assets -913,126 -1,065,634 -739,153 -365,873 -312,739 -90,971 -58,444
　Disposal of Fixed Assets 190 98 38 0 285 0 0
　Increase in Investments -214,601 -2,246,692 -4,518,730 -586,984 -231,402 -790,000 -767,000
　Decrease in Investments 644,770 1,558,901 4,642,246 125,108 1,224,625 800,970 290,148
　Net Cash Flow with Related Parties 178,473 2,000 4,619,560 0 0 0 0
　Others -1,238,150 -1,098,461 -9,309,848 -1,811,940 153,864 -274,210 -41,000
Net Cash Flow before Financing Activities -3,458,873 -4,801,817 -5,538,105 -4,274,946 -189,449 -866,567 -961,671
Net Cash Flow from Financing Activities 2,996,966 5,082,187 4,957,950 2,150,631 4,466,710 114,247 1,666,204
　New Loans 1,080,172 1,463,083 372,178 43,000 287,000 10,000 0
　Loans Repayment -392,738 -278,720 -33,788 -19,336 -5,000 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Equity Financing 2,131,059 3,895,824 0 2,126,967 4,184,710 104,247 1,666,205
　Net Cash Flow with Related Parties 178,473 2,000 4,619,560 0 0 0 0
　Others 0 0 0 0 0 0 -1
Increase(Decrease) in Cash & Cash Equivalents -461,907 280,370 -580,155 -2,124,315 4,277,261 -752,320 704,533
Cash & Cash Equivalents at Beginning of Year 1,359,408 1,276,178 2,425,806 4,524,854 183,761 962,991 236,072
Net Cash Flow due to Change in Exchange Rate/Others 118,664 -197,140 -569,473 25,267 63,832 -26,910 22,386
Cash & Cash Equivalents at End of Year 1,016,165 1,359,408 1,276,178 2,425,806 4,524,854 183,761 962,991
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved